PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #Finance–Eyevensys has entered into strategic engagements with US-based medical device manufacturers Phillips-Medisize and Minnetronix Medical.
Author: Business Wire
Aerie Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Ault Global Holdings Announces Adtech Pharma, Inc., an Innovative Biotech, Appoints Jodi Brichan to Its Board of Directors
LAS VEGAS–(BUSINESS WIRE)—- $AGH #AP–Ault Global Holdings Announces Adtech Pharma, Inc., an Innovative Biotech, Appoints Jodi Brichan to Its Board of Directors
2021 Report on Global Cataract Drugs In Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Cataract (Ophthalmology) pipeline landscape. Cataract is a clouding…
Horizon Therapeutics plc Announces Agenda for Virtual R&D Day for Investors and Analysts on Sept. 29, 2021
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the agenda for its virtual R&D Day for investors and analysts on Sept. 29, 2021. During the event, Horizon’s R&D leadership, executives and key opinion leaders wil…
2021 Allergic Conjunctivitis Report on Drugs in Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Conjunctivitis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline lan…
Squid Healthcare Announces FDA 510(k) Submission for EyeMask MD®
DALLAS–(BUSINESS WIRE)– #510k–Squid Healthcare Announces FDA 510(k) Submission for EyeMask MD® Intended for Periocular Wellness after Surgical and Non-Surgical Procedures
Study Shows Heru’s Automated Visual Field Testing Platform Delivers Strong Correlation to Humphrey Field Analyzer
MIAMI–(BUSINESS WIRE)–A report by Heru Inc., the innovative vision diagnostics and augmentation leader, indicates that visual field test results from its wearable platform, re:Vive by Heru, are strongly correlated to the ZEISS Humphrey Field Analyzer…
Ocular Therapeutix™ Appoints Merilee Raines to Its Board of Directors
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
2021 Report on Corneal Neovascularization Drugs In Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Corneal Neovascularization (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Corneal Neovascularization (Ophthalmology) pipeli…
jCyte® Announces Appointment of Dr. Rebecca Kammer as Vice President of Clinical Operations
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced today the continued expansion of the Company’s leadership team with the appo…
Warby Parker Releases Financial Guidance for the Third Quarter and Fiscal Year 2021 and Fiscal Year 2022
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (the “Company”), a founder-led direct-to-consumer eyewear brand, today issued guidance for the third quarter ending September 30, 2021 and for the fiscal years ending December 31, 2021 and 2022. “As we look …
US Eye Adds New Partnerships in Virginia, North Carolina, South Carolina and Florida
SARASOTA, Fla.–(BUSINESS WIRE)– #Eyecare–US Eye, a physician-led network of patient-centric eye care practices, has expanded its practice base to 50 clinics and five surgery centers.
Aerie Pharmaceuticals, Inc. Announces the Appointment of Interim Executive Chair and Departure of Chairman and CEO
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company, today announced that it is executing its succession plan for its long-serving Chairman and CEO and that effective September 17, 2021, Vicen…
Global Synoptophore Markets 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Synoptophore Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The synoptophore market is projected to register a CAGR of around 4% during th…
Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Global Dry Eye Treatment Devices Market Size, Share & Trends Analysis Report 2021-2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Treatment Devices Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global dry eye treatment devices market size is estimated to reach USD 414.2 million by 2028. It is anticip…
Optic Neuritis (Ophthalmology) Drugs Pipeline Guide 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuritis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information on the therapeutics under development for Optic Neurit…
Global Eye Care Surgical Devices Market 2021-2025: High Incidence of Eye Diseases and growing Number of MI Glaucoma Surgeries Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eye Care Surgical Devices Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The eye care surgical devices market is poised to grow by $ 3.49 bn during 2021-2025, progressing at a CAGR of …